Chelation therapy EDTA. Myths and Facts
Chelation therapy Center
WRÓBEL
MED Bydgoszcz
(Wersenian sodu) Na2 EDTA (disodium ethylenediamine
tetra-acetic acid) is a pharmacopeic drug (/CAS 139-33-3/ LEKI WSPÓŁCZESNEJ
TERAPII WYDANIE XIX 2009)
Na2 EDTA is a widely used drug by
toxicological centers as a therapy for severe, life-threatening poisoning with
heavy metal, and especially with lead. EDTA chelates, that is binds the metal
atoms, forming a complex or chelate, which is soluble in water. The complex is
completely excreted from the body after several hours. EDTA can practically
chelate all metal elements from the Medeleev periodic table, however, it has
the highest affinity for heavy metals toxic for human life such as lead,
mercury, cadmium, aluminum, and excess of other metals in the body.
Na2 EDTA used in multiple intravenous
infusions in small doses is beneficial for patients who do not respond any
longer to previous long-term and intensive treatment with other drugs. During
my 10-year long practice of treating several thousand patients with chelation
therapy I had not encountered a single case when the health was not improved in
patients who did not interrupt the therapy after a few infusions. The
improvement of health after a few infusions is seen only in rare cases; usually
it is seen after ten to twenty infusions and as a rule after twenty or
sometimes even after thirty intravenous infusions. Every person after the age of 50-60 years
accumulated in his/her organs a depot a variety of metals that were ingested
with artificially processed food, water, especially originating from the wells,
various commercial drinks, consumption of a variety of uncontrolled food
supplements or even from long use of some drugs that contain metal ions. Asymptomatic
patients who do not report any problem and are apparently healthy after undergoing
prophylactic therapy report later significant improvement in their physical and
intellectual performance, higher level of vital energy and feel rejuvenated by
ten years.
Therefore, I believe that
people over fifty years of age, not only those who show some clinical symptoms of ailments, but also those
who feel healthy, have in their organism excess of one or a few toxic metals. Based
on our long-term urine analysis (using the method of ICP-MS, Inductively
Coupled Plasma Mass Spectrometry –
performed by Pracownia Monitoringu Biologicznego, Zakładu
Bezpieczeństwa Chemicznego, Instytutu
Medycy Pracy w ŁODZI, Poland) we classify such a condition as a:
SYNDROME OF
CHRONIC SUBCLINICAL METAL POISONING.
Particularly interesting is that while the
level of all metals is increased in the urine three hours after intravenous administration
of Na2 EDTA compared to the level before chelation treatment, the
level of calcium and magnesium instead of rising is decreased by one half, and
this is observed during a dozen or so of sessions.
On example level calcium and
magnesium before and after chelation:
Patient J.Ch:
Calcium (Ca) before 3,37 mmol/l after
1,71mmol/l
Magnezium (Mg)
2,99 mmol/l 1.00mmol/l
Patient W.Z:
Calcium (Ca) before
2,45 mmol/l after 1,22
mmol/l
Magnezium (Mg)
2,49 mmol/l 0,79mmol/l
Patient O.A:
Calcium (Ca) before 8,94 mmol/l after
2,38 mmol/l
Magnezium (Mg)
4,02 mmol/l 0,89 mmol/l
Patient H.W:
Calcium (Ca) before 4,47 mmol/l after
3,24 mmol/l
Magnezium (Mg)
2,61 mmol/l 0,86 mmol/l
Like dozens of other patients.
This means that it is not true that the chelation removes calcium and magnesium from the organism.
This means that it is not true that the chelation removes calcium and magnesium from the organism.
One could explain this
phenomenon by theorizing that probably after the removal of lead and cadmium,
calcium and magnesium return to their locations, that is calcium to the bones
and magnesium to the variety of enzymes from which they were previously
displaced by stronger metals.
In the organism there are no „empty spaces,” no
enzymes waiting to be combined with magnesium for in its place other metals are
absorbed, mainly cadmium, aluminum, and others. These are stronger metals than
magnesium and magnesium is not able to displace them. The only method to remove
these toxic metals from the human organism seems to be the intravenous
administration of the Na2 EDTA.
Chemical element magnesium is necessary for the proper
function of the organism. Its deficiency in tens of enzymes causes their
inactivation to various digress which result in various illnesses and
precocious aging.
ALUMINUM is deposited in various tissues and
especially and irreversably in the brain cells. As a result follow decrease in memory and balance disorder. Aluminium also
blocks catecholamines, reabsorbtion of neurotransmitters, serotonin, dopamine,
and noradrenalin. Aluminum is always accumulated in large quantities in the brain
cells in cases of Alzheimer disease leading to severe dementia. I have observed in some patients
undergoing chelation therapy a four-fold increase of aluminum level in urine after
treatment indicating an excessive level of this toxic metal in the organism.
LEAD accumulating mainly in bones and weakening their
structure, and CADMIUM causing osetomalacia are principal factors for the loss
of height, often by the size of a head, occurring with age.
IRON, is the most important metal in the body,
however, when it occurs in excessive quantity it becomes very toxic and is responsible
for many illnesses, especially in the advanced age, but beginning usually at
the age of 50. There are several causes that may produce excessive level of
iron, such as congenital genetic factors conditioned e.g. by the gene of
hemochromatose found on avergae in one of ten people; but this illness appears in
1/1200 to 1/1400 patients in the form of diabetes, damage to the liver, spleen,
joints, heart and testicles. Deposits of
hemosiderin are accumulated in these organs. At the age of 40-60 years
occur liver enlargement, gastro-intestinal complaints, permanent joint pains,
disorders of heart rhythm, decrease in libido, and permanent fatigue. Often in
these patients occurs gray-brown skin coloration especially on the face, and
the liver cancer may develop. Deposits of iron also are accumulated in
PARKINSON’S DISEAE. The first symptoms of Parkinson’s appear when already 80%
of brain base nuclei are destroyed by iron deposits. Iron also is deposited in muscles. Heart muscle in
older persons is not red but brown due to the accumulated iron deposits. Certainly,
the metals mentioned above alone are not the only cause of those diseases that
are at least partially produced by genetic factors, however, one cannot exclude
that their excess in the body accelerates the tempo of their development.
Large quantity of iron also is deposited in
microvascular area and in small arteries. Their thickened and rigid walls containing
deposits of phospholipids, calcium, aluminum, copper, and iron do not respond
to any vasodilating drugs. Clinical improvements observed, after chelation
treatment of many ailments, such as regression of angina pectoris, regression
of pains in the lower limbs, improvement of eye sight, of hearing, and of breathing
capacity, indicate that the walls of blood vessels become more elastic increasing
the blood circulation.
disodium ethylenediamine tetra-acetic acid (WERSENIAN SODU) as inhibitor of Zinc-linked METALOPROTEINS
During my studies on the positive role of chelation
therapy by disodium ethylenediamine tetra-acetic acid I have observed, in
addition, that this drug is inhibiting a dangerous metalloproteinase MMP 9. In the
urine tests described above, we have observed that increase in the level of
various metals after chelation treatment, though it varied from patient to
patient, was on the average several-fold, but increase in zinc was from 9 to 61 times higher.
On example author:
Level of metal in urine Before treatment After
treatment
Aluminium 11.1
µg/L
34.1 µg/L
Lead 1.6 µg /g
creatinine 18.2 µg /g creatinine
Zinc /Zn/ 325
µg /g creatinine 19370.9
µg /g creatinine
Increase in
zinc 59-fold
For example patient
J.CH (man age 69):
Level
of metal in urine Before
treatment After treatment
Cobalt (Co) 0,29 µg/L 0,96 µg/L
Iron (Fe) 27,3 µg/L 959 µg/L
Chrome (Cr) 2,28 µg/L 1,77 µg/L
Mercury (Hg) 1,05 µg/L 1,05 µg/L
Copper (Cu) 16,2 µg/L 45,5 µg/L
Nickel (Ni) 0,57 µg/L 1,92 µg/L
Lead (Pb) 8,75 µg/L 25,6 µg/L
Zinc (Zn) 272,6 µg/L 31 512 µg/L
Cadmium (Cd) 1,05 µg/L 7,04 µg/L
Alluminium (Al) 31 µg/L 74,5 µg/L
Manganese (Mn) 0,62 µg/L 31,3 µg/L
Calcium (Ca) 3,37 mmol/l 1,71mmol/l
Magnezium (Mg)
2,99 mmol/l 1.00mmol/l
For example patient
S.P (women age 29) :
Level
of metal in urine Before
treatment After treatment
Cobalt (Co) 0,27 µg/L 0,26 µg/L
Iron (Fe) 71,3 µg/L 98,0
µg/L
Chrome (Cr) 3,2 µg/L 1,64 µg/L
Copper (Cu) 7,62µg/L 16,3 µg/L
Nickel (Ni) 2,31 µg/L 7,64 µg/L
Lead (Pb) 1,38 µg/L 6,91 µg/L
Zinc (Zn) 386 µg/L 7 759
µg/L
Cadmium (Cd) 0,30 µg/L 0,61 µg/L
Alluminium (Al) 157 µg/L 726 µg/L
Manganese (Mn) 1,04 µg/L 18,7 µg/L
Calcium (Ca) 2,88 mmol/l 0,83 mmol/l
Magnezium (Mg)
2,40 mmol/l 0,90 mmol/l
Investigating the reltionship between the quantity of
excreted zinc and the level of zinc-linked metalloproteinases in the human body, we have tested the level of MMP 9 in the
blood serum before chelation and 24 hours after chelation (tests performed by
clinical immunological laboratory in Bydgoszcz). All 11 patients showed a
decrease in level of MMP 9 from 30-70 %. One
exception constituted a patient who had previously a severe viral meningitis
(herpes zoster).
Level of MMP9 before chelation 24
hours later after chelation
Patient W.Z:
level of MMP 9 222,99
ng/m 173,81 ng/mL in blood serum
Patient W.B:
level of MMP 9 189,27
ng/m 75,22 ng/mL in blood serum
Patient N.S:
level of MMP 9 224,83
ng/m 188,25 ng/mL in blood serum
Patient W.W:
level of MMP 9 180,12
ng/m 101,09 ng/mL in blood serum
Patient M.E:
level of MMP 9 146,06
ng/m 89,19 ng/mL in blood serum
Patient M.M:
level of MMP 9 150,47
ng/m 76,00 ng/mL in blood serum
Patient B.B:
level of MMP 9 218,26
ng/m 131,68 ng/mL in blood serum
Patient Ł.G:
level of MMP 9 185,15
ng/m 101,78 ng/mL in blood serum
Patient Ł.W:
level of MMP 9 146,64
ng/m 53,81 ng/mL in blood serum
Patient R.D:
level of MMP 9 178,04
ng/m 139,23 ng/mL in blood serum
Patient M.M (who had previously a severe viral
meningitis - herpes zoster):
level of MMP 9 265,28
ng/m 264,67 ng/mL in blood serum
_________________________________________________
For example my (author) level of MMP 9
before - 180.12 ng/mL and after - 101.09 ng/mL in blood serum
________________________________________________________
There are 22 metalloproteinases in human organism,
such as collagenase, elastase, and the most dangerous MMP 9 and MMP 2. They are
responsible for many chronic diseases of the circulatory system, degenerative
disease of the osteo-articular system, the nervous system, and the neoplastic
metastases.
Doctor of Medicine Wiesław Wróbel
Brak komentarzy:
Prześlij komentarz